MAP1LC3B2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.533600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.668600E-01
Normal-vs-Stage2
6.270000E-01
Normal-vs-Stage3
3.696800E-01
Normal-vs-Stage4
6.552200E-02
Stage1-vs-Stage2
6.413000E-01
Stage1-vs-Stage3
3.179200E-01
Stage1-vs-Stage4
1.711600E-01
Stage2-vs-Stage3
1.685400E-01
Stage2-vs-Stage4
3.608400E-01
Stage3-vs-Stage4
1.602480E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.802000E-01
Normal-vs-AfricanAmerican
2.381600E-01
Normal-vs-Asian
8.038600E-01
Caucasian-vs-AfricanAmerican
1.514210E-01
Caucasian-vs-Asian
2.307200E-01
AfricanAmerican-vs-Asian
5.449700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.345800E-01
Normal-vs-Female
6.774600E-01
Male-vs-Female
5.282200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.489800E-01
Normal-vs-Age(41-60Yrs)
3.427200E-01
Normal-vs-Age(61-80Yrs)
8.165400E-01
Normal-vs-Age(81-100Yrs)
8.151800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.096400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.044600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.691000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.123000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.110800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.267600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.994800E-01
Normal-vs-Daily Drinker
7.782800E-01
Normal-vs-Weekly Drinker
7.726600E-01
Normal-vs-Occasional Drinker
4.218800E-01
Normal-vs-Social Drinker
8.911600E-01
Non Drinker-vs-Daily Drinker
3.861400E-01
Non Drinker-vs-Weekly Drinker
6.939200E-01
Non Drinker-vs-Occasional Drinker
1.087360E-01
Non Drinker-vs-Social Drinker
9.900800E-01
Daily Drinker-vs-Weekly Drinker
3.080200E-01
Daily Drinker-vs-Occasional Drinker
2.838200E-02
Daily Drinker-vs-Social Drinker
4.472400E-01
Weekly Drinker-vs-Occasional Drinker
2.874600E-01
Weekly Drinker-vs-Social Drinker
7.149000E-01
Occasional Drinker-vs-Social Drinker
1.186640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.135200E-01
Normal-vs-Grade 2
1.491370E-01
Normal-vs-Grade 3
2.248600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.928200E-02
Grade 1-vs-Grade 3
1.203350E-01
Grade 1-vs-Grade 4
4.135200E-01
Grade 2-vs-Grade 3
8.190800E-01
Grade 2-vs-Grade 4
1.491370E-01
Grade 3-vs-Grade 4
2.248600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.611000E-01
Normal-vs-NonDiabetic
7.314400E-01
Diabetic-vs-NonDiabetic
9.549200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.658600E-01
Normal-vs-NoPancreatitis
7.171600E-01
Pancreatitis-vs-NoPancreatitis
9.086000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.935600E-01
Normal-vs-N1
6.298600E-01
N0-vs-N1
6.890000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.400000E-01
Normal-vs-TP53-NonMutant
9.696800E-01
TP53-Mutant-vs-TP53-NonMutant
2.343800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
